Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives.
Mol Pharm. 2021 Jun 7;18(6):2142-2160. doi: 10.1021/acs.molpharmaceut.1c00297. Epub 2021 May 19. Mol Pharm. 2021. PMID: 34010004 Review.